Selective beta-blocker bisoprolol: effectiveness and safety in complex treatment of patients with chronic heart failure and Type 2 diabetes mellitus. RAMBO-DM CHF Study results

Selective beta-blocker bisoprolol: effectiveness and safety in complex treatment of patients with chronic heart failure and Type 2 diabetes mellitus. RAMBO-DM CHF Study results

Aim. To assess effectiveness and safety of a selective beta-blocker bisoprolol in patients with chronic heart failure (CHF) and Type 2 diabetes mellitus (DM-2).Material and methods. In total, 81 patients with mild to moderate CHF, NYHA Functional Class (FC) II-III, left ventricular ejection fraction...

Full description

Bibliographic Details
Main Authors: Yu. V. Lapina, A. A. Petrukhina, O. Yu. Narusov, V. Yu. Mareev, M. G. Bolotina, M. V. Shestakova, V. P. Masenko, G. N. Litonova, N. A. Baklanova, Yu. N. Belenkov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
chronic heart failure
type 2 diabetes mellitus
bisoprolol
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1552

Internet

https://cardiovascular.elpub.ru/jour/article/view/1552

Similar Items